|
|
|
|
K Vosseller, G Stella, NS Yee and P Besmer
Molecular Biology Program, Sloan Kettering Institute, New York, New York 10021, USA.
In bone marrow-derived mast cells (BMMCs), the Kit receptor tyrosine kinase mediates diverse responses including proliferation, survival, chemotaxis, migration, differentiation, and adhesion to extracellular matrix. In connective tissue mast cells, a role for Kit in the secretion of inflammatory mediators has been demonstrated as well. We recently demonstrated a role for phosphatidylinositide-3' (PI 3)-kinase in Kit-ligand (KL)-induced adhesion of BMMCs to fibronectin. Herein, we investigated the mechanism by which Kit mediates enhancement of Fc epsilon RI-mediated degranulation, cytoskeletal rearrangements, and adhesion in BMMCs. Wsh/Wsh BMMCs lacking endogenous Kit expression, were transduced to express normal and mutant Kit receptors containing Tyr-->Phe substitution at residues 719 and 821. Although the normal Kit receptor fully restored KL-induced responses in Wsh/Wsh BMMCs, Kit gamma 719F, which fails to bind and activate PI 3-kinase, failed to potentiate degranulation and is impaired in mediating membrane ruffling and actin assembly. Inhibition of PI 3-kinase with wortmannin or LY294002 also inhibited secretory enhancement and cytoskeletal rearrangements mediated by Kit. In contrast, secretory enhancement and adhesion stimulated directly through protein kinase C (PKC) do not require PI 3-kinase. Calphostin C, an inhibitor of PKC, blocked Kit- mediated adhesion to fibronectin, secretory enhancement, membrane ruffling, and filamentous actin assembly. Although cytochalasin D inhibited Kit-mediated filamentous actin assembly and membrane ruffling, secretory enhancement and adhesion to fibronectin were not affected by this drug. Therefore, Kit-mediated cytoskeletal rearrangements that are dependent on actin polymerization can be uncoupled from the Kit-mediated secretory and adhesive responses. Our results implicate receptor-proximal PI 3-kinase activation and activation of a PKC isoform in Kit-mediated secretory enhancement, adhesion, and cytoskeletal reorganization.
This article has been cited by other articles:
![]() |
M.-S. Kim, H. S. Kuehn, D. D. Metcalfe, and A. M. Gilfillan Activation and Function of the mTORC1 Pathway in Mast Cells J. Immunol., April 1, 2008; 180(7): 4586 - 4595. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kalesnikoff, E. J. Rios, C.-C. Chen, S. Nakae, B. A. Zabel, E. C. Butcher, M. Tsai, S.-Y. Tam, and S. J. Galli RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. PNAS, February 21, 2006; 103(8): 2659 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kulka, N. Fukuishi, M. Rottem, Y. A. Mekori, and D. D. Metcalfe Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to Fc{epsilon}RI-mediated activation J. Leukoc. Biol., February 1, 2006; 79(2): 339 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tanaka, M. Konno, S. Muto, N. Kambe, E. Morii, T. Nakahata, A. Itai, and H. Matsuda A novel NF-{kappa}B inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors Blood, March 15, 2005; 105(6): 2324 - 2331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit Stem Cells, January 1, 2005; 23(1): 16 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Agosti, S. Corbacioglu, I. Ehlers, C. Waskow, G. Sommer, G. Berrozpe, H. Kissel, C. M. Tucker, K. Manova, M. A.S. Moore, et al. Critical Role for Kit-mediated Src Kinase But Not PI 3-Kinase Signaling in Pro T and Pro B Cell Development J. Exp. Med., March 15, 2004; 199(6): 867 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rothschild, C. M. Sottas, H. Kissel, V. Agosti, K. Manova, M. P. Hardy, and P. Besmer A Role for Kit Receptor Signaling in Leydig Cell Steroidogenesis Biol Reprod, September 1, 2003; 69(3): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lam, J. Kalesnikoff, C. W. K. Lee, V. Hernandez-Hansen, B. S. Wilson, J. M. Oliver, and G. Krystal IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor Blood, August 15, 2003; 102(4): 1405 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gu, M. C. Byrne, N. C. Paranavitana, B. Aronow, J. E. Siefring, M. D'Souza, H. F. Horton, L. A. Quilliam, and D. A. Williams Rac2, a Hematopoiesis-Specific Rho GTPase, Specifically Regulates Mast Cell Protease Gene Expression in Bone Marrow-Derived Mast Cells Mol. Cell. Biol., November 1, 2002; 22(21): 7645 - 7657. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Scheid, M. Huber, J. E. Damen, M. Hughes, V. Kang, P. Neilsen, G. D. Prestwich, G. Krystal, and V. Duronio Phosphatidylinositol (3,4,5)P3 Is Essential but Not Sufficient for Protein Kinase B (PKB) Activation; Phosphatidylinositol (3,4)P2 Is Required for PKB Phosphorylation at Ser-473. STUDIES USING CELLS FROM SH2-CONTAINING INOSITOL-5-PHOSPHATASE KNOCKOUT MICE J. Biol. Chem., March 8, 2002; 277(11): 9027 - 9035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Taylor, J. Dastych, D. Sehgal, M. Sundstrom, G. Nilsson, C. Akin, R. G. Mage, and D. D. Metcalfe The Kit-activating mutation D816V enhances stem cell factor-dependent chemotaxis Blood, August 15, 2001; 98(4): 1195 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ballestrem, B. Wehrle-Haller, B. Hinz, and B. A. Imhof Actin-dependent Lamellipodia Formation and Microtubule-dependent Tail Retraction Control-directed Cell Migration Mol. Biol. Cell, September 1, 2000; 11(9): 2999 - 3012. [Abstract] [Full Text] |
||||
![]() |
J. Sawada, A. Itakura, A. Tanaka, T. Furusaka, and H. Matsuda Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways Blood, March 15, 2000; 95(6): 2052 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lu-Kuo, D. A. Fruman, D. M. Joyal, L. C. Cantley, and H. R. Katz Impaired Kit- but Not Fcepsilon RI-initiated Mast Cell Activation in the Absence of Phosphoinositide 3-Kinase p85alpha Gene Products J. Biol. Chem., February 25, 2000; 275(8): 6022 - 6029. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Berrozpe, I. Timokhina, S. Yukl, Y. Tajima, M. Ono, A. D. Zelenetz, and P. Besmer The Wsh, W57, and Ph Kit Expression Mutations Define Tissue-Specific Control Elements Located Between -23 and -154 kb Upstream of Kit Blood, October 15, 1999; 94(8): 2658 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Broudy, N. L. Lin, W. C. Liles, S. J. Corey, B. O'Laughlin, S. Mou, and D. Linnekin Signaling via Src Family Kinases Is Required for Normal Internalization of the Receptor c-Kit Blood, September 15, 1999; 94(6): 1979 - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imai and D. R. Clemmons Roles of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Pathways in Stimulation of Vascular Smooth Muscle Cell Migration and Deoxyriboncleic Acid Synthesis by Insulin-Like Growth Factor-I Endocrinology, September 1, 1999; 140(9): 4228 - 4235. [Abstract] [Full Text] |
||||
![]() |
M. A. Adelsman, J. B. McCarthy, and Y. Shimizu Stimulation of beta 1-Integrin Function by Epidermal Growth Factor and Heregulin-beta Has Distinct Requirements for erbB2 but a Similar Dependence on Phosphoinositide 3-OH Kinase Mol. Biol. Cell, September 1, 1999; 10(9): 2861 - 2878. [Abstract] [Full Text] |
||||
![]() |
M. Haslauer, K. Baltensperger, and H. Porzig Erythropoietin- and Stem Cell Factor-Induced DNA Synthesis in Normal Human Erythroid Progenitor Cells Requires Activation of Protein Kinase Calpha and Is Strongly Inhibited by Thrombin Blood, July 1, 1999; 94(1): 114 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Leslie, J. O'Prey, C. Bartholomew, and P. R. Harrison An Activating Mutation in the Kit Receptor Abolishes the Stroma Requirement for Growth of ELM Erythroleukemia Cells, But Does Not Prevent Their Differentiation in Response to Erythropoietin Blood, December 15, 1998; 92(12): 4798 - 4807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dastych, D. Taub, M. C. Hardison, and D. D. Metcalfe Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis Am J Physiol Cell Physiol, November 1, 1998; 275(5): C1291 - C1299. [Abstract] [Full Text] [PDF] |
||||